The Relationship Between Vitamin D Levels, Inflammatory Parameters and Disease Severity of COVID-19 Infection
NCT04945577 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2021-06-30
Summary
Vitamin D deficiency increases the susceptibility to respiratory virus infections and the severity of infections. Inflammation plays a key role in pathogenesis in COVID19 while identifying clinical course and prognosis COVID19.The aim of this study was to determine the relationship between 25OH vitamin D levels, inflammatory laboratory parameters of neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), C-reactive protein (CRP) levels and disease severity of COVID19 infection.
Conditions
- Vitamin D Deficiency
- Covid19
Interventions
- DIAGNOSTIC_TEST
-
Inflammatory Parameters
Laboratory measurement of patient's inflammatory status in unit of % and mg/dl
- OTHER
-
25 OH Vitamin D Level
Laboratory measurement of patient's 25 OH vitamin D level in unit of ng/dl
Sponsors & Collaborators
-
Fatih Sultan Mehmet Training and Research Hospital
lead OTHER
Eligibility
- Min Age
- 16 Years
- Max Age
- 97 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-07-01
- Primary Completion
- 2020-08-01
- Completion
- 2020-08-01
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Evaluation of the Relationship Between Zinc Vitamin D and b12 Levels in the Covid-19 Positive Pregnant Women
NCT04407572 ·Status: COMPLETED
-
Vitamin D Supplementation and Clinical Improvement in COVID-19
NCT05126602 ·Status: COMPLETED ·Phase: NA
-
Assessment of Vitamin D Level in COVID-19
NCT04949412 ·Status: COMPLETED
-
Vitamine D in Post-COVID Patients
NCT04969237 ·Status: COMPLETED
-
Vitamin D Supplementation in the Prevention and Mitigation of COVID-19 Infection
NCT04482673 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Vitamin D Zinc Fever
NCT01080950 ·Status: UNKNOWN
-
Vitamine D3 Supplementation in Patients With Serum Values +/- 20ng/ml
NCT04810949 ·Status: TERMINATED ·Phase: NA
-
Vitamin D Effects in Overweight Patients
NCT00493012 ·Status: COMPLETED ·Phase: NA
-
Short Term, High Dose Vitamin D Supplementation for COVID-19
NCT04459247 ·Status: COMPLETED ·Phase: NA
-
Vitamin D Deficiency and Asthma Exacerbation
NCT02661191 ·Status: COMPLETED ·Phase: NA
-
Vitamin D Status Impacts Inflammation and Risk of Infections During Pregnancy
NCT01815047 ·Status: COMPLETED ·Phase: NA
-
Retinal Changes in Vitamin D Deficiency
NCT04891211 ·Status: COMPLETED ·Phase: NA
-
Effect of Vitamin D on Morbidity and Mortality of the COVID-19
NCT04552951 ·Status: UNKNOWN ·Phase: PHASE4
-
Baseline Vitamin D Deficiency and COVID-19 Disease Severity
NCT04628000 ·Status: COMPLETED
-
Vitamin D on Prevention and Treatment of COVID-19
NCT04334005 ·Status: UNKNOWN ·Phase: NA
-
High Dose Vitamin-D Substitution in Patients With COVID-19: a Randomized Controlled, Multi Center Study
NCT04525820 ·Status: COMPLETED ·Phase: NA
-
Increased Risk of Severe Coronavirus Disease 2019 in Patients With Vitamin D Deficiency
NCT04403932 ·Status: COMPLETED
-
Vitamin D Supplementation and Clinical Outcomes in Severe COVID-19 Patients
NCT05384574 ·Status: UNKNOWN ·Phase: NA
-
Vitamin D Status and Immune Function
NCT02416895 ·Status: COMPLETED
-
Vitamin D3 Supplementation to Prevent Respiratory Tract Infections
NCT04596657 ·Status: COMPLETED ·Phase: NA
-
COVID-19 Morbidity in Healthcare Workers and Vitamin D Supplementation
NCT05037253 ·Status: COMPLETED ·Phase: PHASE4
-
Short Term, High Dose Vitamin D Supplementation in Moderate to Severe COVID-19 Disease
NCT04952857 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Vitamin D Supplementation on Disease Activity Markers in Systemic Lupus Erythematosus (SLE)
NCT01425775 ·Status: COMPLETED ·Phase: NA
-
Serum Levels of 25-Hydroxy Vitamin D in Patients With Moderate and Severe Erectile Dysfunction
NCT03867929 ·Status: COMPLETED
-
Vitamin D Supplementation in Patients With COPD
NCT02122627 ·Status: COMPLETED ·Phase: NA